Regeneron Hires 150th Employee For Its Limerick Facility

Regeneron Pharmaceuticals has announced it has hired its 150th employee for its Limerick facility, as it completes its first of a multi-year construction and development programme for the site.

The over $300 million investment in a biopharmaceutical production facility within an 11.88 hectare site at Raheen Business Park, Regeneron’s first facility outside the United States, is on track to commence operations in 2016. In addition to the 150 full-time staff in place already, the site is expected to see employment rise to over 300 people including scientists, engineers, technicians and administrative personnel. Already, 1,200 construction personnel have worked on-site over the course of the past year.

Speaking at an event on-site in Limerick to mark the first year of development at the facility, Dan Van Plew, Senior Vice President and General Manager of Industrial Operations and Product Supply (IOPS) at Regeneron, said: "Our approved drugs and robust development pipeline have transformed Regeneron into one of the largest and fastest-growing biopharmaceutical companies in the United States. As our second industrial production site, and the first outside the United States, the Raheen Business Park site will play a prominent role in the future of the company."

(CD/MH)